Gajendra Choudhary

Chandigarh, CH, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

AI in biomolecular structural data analysis.

AI in biomolecular structural data analysis.

Journal: Progress in molecular biology and translational science

Published: April 15, 2026

Computational drug repurposing identifies flavoxate as a novel NLRP3 inflammasome inhibitor for Alzheimer's disease therapy.

Computational drug repurposing identifies flavoxate as a novel NLRP3 inflammasome inhibitor for Alzheimer's disease therapy.

Journal: In silico pharmacology

Published: March 27, 2026

In silico and in vitro antibacterial investigation of Origanum majorana L. leaves extract against gram-positive and gram-negative bacteria.

In silico and in vitro antibacterial investigation of Origanum majorana L. leaves extract against gram-positive and gram-negative bacteria.

Journal: In silico pharmacology

Published: January 08, 2026

Computational discovery of Ethyl gallate as a novel toll-interacting-protein (TOLLIP) interactor: a therapeutic strategy against paraquat-induced toxicity.

Computational discovery of Ethyl gallate as a novel toll-interacting-protein (TOLLIP) interactor: a therapeutic strategy against paraquat-induced toxicity.

Journal: In silico pharmacology

Published: August 08, 2025

Therapeutic potential of 6BIO and DKK1-LRP6 inhibitor in Wnt/β-catenin pathway modulation for amyloid-β-induced Alzheimer's disease model.

Therapeutic potential of 6BIO and DKK1-LRP6 inhibitor in Wnt/β-catenin pathway modulation for amyloid-β-induced Alzheimer's disease model.

Journal: Journal of Alzheimer's disease : JAD

Published: July 30, 2025

Re-emergence of COVID-19 and preparedness.

Re-emergence of COVID-19 and preparedness.

Journal: Indian journal of pharmacology

Published: June 14, 2025

In silico drug repurposing targeting fusion and nucleoprotein of human metapneumovirus: A step toward pandemic preparedness.

In silico drug repurposing targeting fusion and nucleoprotein of human metapneumovirus: A step toward pandemic preparedness.

Journal: Indian journal of pharmacology

Published: June 10, 2025

A novel modulator of the Axin/β-Catenin interaction to restore EAAT2 expression in alzheimer's disease: an in-silico and in-vitro approach.

A novel modulator of the Axin/β-Catenin interaction to restore EAAT2 expression in alzheimer's disease: an in-silico and in-vitro approach.

Journal: Metabolic brain disease

Published: May 08, 2025

Natural angiotensin II type 1 receptor inhibitors: Virtual screening and in vitro evaluation of beta-1,2,3,4,6-penta-O-galloyl-d-glucopyranose, icarrin, and sesamin for osteoarthritis therapy.

Natural angiotensin II type 1 receptor inhibitors: Virtual screening and in vitro evaluation of beta-1,2,3,4,6-penta-O-galloyl-d-glucopyranose, icarrin, and sesamin for osteoarthritis therapy.

Journal: International journal of biological macromolecules

Published: December 12, 2024

I n-silico drug repurposing for lysyl oxidase inhibition and ferroptosis prevention in epilepsy.

I n-silico drug repurposing for lysyl oxidase inhibition and ferroptosis prevention in epilepsy.

Journal: In silico pharmacology

Published: August 25, 2024

In silico screening and molecular dynamic simulations of FDA-approved drugs as an inhibitor of trypanothione reductase of Leishmania donovani.

In silico screening and molecular dynamic simulations of FDA-approved drugs as an inhibitor of trypanothione reductase of Leishmania donovani.

Journal: Experimental parasitology

Published: July 29, 2024

The pivotal role of artificial intelligence in enhancing experimental animal model research: A machine learning perspective.

The pivotal role of artificial intelligence in enhancing experimental animal model research: A machine learning perspective.

Journal: Indian journal of pharmacology

Published: January 29, 2024

Showing 1-12 of 18

Last Updated: 09/26/2026